These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6183699)
61. Assay of immunomodulation by type I interferon in vivo. De Maeyer E Methods Enzymol; 1981; 79(Pt B):493-5. PubMed ID: 6173698 [No Abstract] [Full Text] [Related]
62. Lethality of interferon preparations for newborn mice. Gresser I; Tovey MG; Maury C; Chouroulinkov I Nature; 1975 Nov; 258(5530):76-8. PubMed ID: 1186883 [No Abstract] [Full Text] [Related]
63. Effects of intralesional interferon on neuroblastoma: changes in histology and DNA content distribution of tumor masses. Sawada T; Takamatsu T; Tanaka T; Mino M; Fujita K; Kusunoki T; Arizono N; Fukuda M; Kishida T Cancer; 1981 Nov; 48(10):2143-6. PubMed ID: 6170415 [TBL] [Abstract][Full Text] [Related]
64. Toxicity of interferon. Priestman TJ; Lucken RN; Finter NB Br Med J (Clin Res Ed); 1981 Aug; 283(6290):562. PubMed ID: 6167311 [No Abstract] [Full Text] [Related]
65. Patient tolerance to interferon: clinical and laboratory assessments. Fischl MA Med Clin North Am; 1986 May; Suppl():41-5. PubMed ID: 2426535 [TBL] [Abstract][Full Text] [Related]
66. Production and preparation of human fibroblast interferon for clinical trials. Leong SS; Horoszewicz JS Methods Enzymol; 1981; 78(Pt A):87-101. PubMed ID: 6173652 [No Abstract] [Full Text] [Related]
67. Development of newbor mice during prolonged treatment with interferon. Gresser I; Bourali C Eur J Cancer (1965); 1970 Dec; 6(6):553-6. PubMed ID: 5504465 [No Abstract] [Full Text] [Related]
68. Towards the clinical use of interferon. Cantell K Endeavour; 1978; 2(1):27-30. PubMed ID: 95532 [No Abstract] [Full Text] [Related]
76. Central nervous system toxicity of biological response modifiers. Triozzi PL; Kinney P; Rinehart JJ Ann N Y Acad Sci; 1990; 594():347-54. PubMed ID: 1696080 [No Abstract] [Full Text] [Related]